Edward M. Basile - Feb 27, 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Director
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol
TMDX
Transactions as of
Feb 27, 2023
Transactions value $
-$390,315
Form type
4
Date filed
2/28/2023, 04:01 PM
Previous filing
Jun 6, 2022
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Sale -$114K -1.5K -6.57% $76.20 21.3K Feb 27, 2023 Direct F1
transaction TMDX Common Stock Sale -$117K -1.5K -7.04% $78.17 19.8K Feb 27, 2023 Direct F2
transaction TMDX Common Stock Sale -$159K -2K -10.09% $79.38 17.8K Feb 27, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $76.00 to $76.54, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $78.00 to $78.50, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $79.25 to $79.50, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.